@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix go: . @prefix Protein: . @prefix sfam: . @prefix geneProductOf: . @prefix hasAgent: . @prefix hgnc: . @prefix species: . @prefix occursIn: . @prefix obo: . @prefix do: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 hasAgent: sub:_2; a go:0016301 . sub:_2 geneProductOf: sfam:PRKC%20Family; a Protein: . sub:_3 hasAgent: sub:_4; a go:0003824 . sub:_4 geneProductOf: hgnc:5014; a Protein: . sub:_5 occursIn: do:1936, obo:UBERON_0001969, species:9606; rdf:object sub:_3; rdf:predicate belv:increases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "kin(p(SFAM:\"PRKC Family\")) -> cat(p(HGNC:HMOX2))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_7; pav:version "20131211" . sub:_6 prov:value "In contrast, HO-2 has low activity at low substrate concentrations, and even its maximum activity is limited to less than 10% that of HO-1 (Table 1) (Maines and Panahian, 2001). However, the enzymatic activity of HO-2 can be increased in a protein kinase C-dependent manner (Dore et al., 1999). "; prov:wasQuotedFrom pubmed:12869663 . sub:_7 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:12869663; prov:wasDerivedFrom beldoc:, sub:_6 . } sub:pubinfo { this: dct:created "2014-07-03T14:32:04.825+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }